-
FATE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Fate Therapeutics (FATE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm |
Cash burn (monthly) | 1.32 mm | 31.25 k | 17.46 mm | 16.38 mm | 9.81 mm | 10.98 mm |
Cash used (since last report) | 6.75 mm | 159.81 k | 89.29 mm | 83.79 mm | 50.15 mm | 56.13 mm |
Cash remaining | 41.39 mm | 47.98 mm | -41.15 mm | -35.65 mm | -2.01 mm | -8.00 mm |
Runway (months of cash) | 31.4 | 1535.2 | -2.4 | -2.2 | -0.2 | -0.7 |
13F holders | Current |
---|---|
Total holders | 158 |
Opened positions | 36 |
Closed positions | 39 |
Increased positions | 44 |
Reduced positions | 48 |
13F shares | Current |
---|---|
Total value | 162.57 bn |
Total shares | 106.52 mm |
Total puts | 15.90 k |
Total calls | 41.30 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Redmile | 12.87 mm | $21.24 bn |
BlackRock | 10.94 mm | $18.05 bn |
Vanguard | 10.33 mm | $17.05 bn |
Boxer Capital Management | 4.96 mm | $13.10 mm |
BLVGF Bellevue | 4.84 mm | $7.99 bn |
Citadel Advisors | 4.38 mm | $7.23 bn |
Deerfield Management | 3.56 mm | $5.87 bn |
JNJ Johnson & Johnson | 3.38 mm | $5.58 bn |
Baker Bros. Advisors | 3.26 mm | $5.38 bn |
EcoR1 Capital | 3.05 mm | $5.03 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 25 | Bahram Valamehr | Stock Option Common Stock | Grant | Acquire A | No | No | 1.25 | 1,300,000 | 1.63 mm | 1,300,000 |
15 Jan 25 | Cindy Tahl | Common Stock | Grant | Acquire A | No | No | 0 | 70,000 | 0.00 | 406,707 |
15 Jan 25 | Cindy Tahl | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 275,000 | 363.00 k | 275,000 |
15 Jan 25 | Jerome Charles Bressi | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 335,203 |
15 Jan 25 | Jerome Charles Bressi | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 250,000 | 330.00 k | 250,000 |
10 Jan 25 | Cindy Tahl | Common Stock | Sell | Dispose S | No | No | 1.55 | 5,654 | 8.76 k | 336,707 |
10 Jan 25 | Jerome Charles Bressi | Common Stock | Sell | Dispose S | No | No | 1.55 | 5,980 | 9.27 k | 270,203 |